Biogen’s Alzheimer’s data spur excitement, confusion about tau-targeting drugs
LONDON — One of the most anticipated Alzheimer’s studies in the past few years has created both enthusiasm and confusion, according to conversations Endpoints News recently had with about 20 scientists, neurologists, investors and drugmakers. Earlier ...
Image: Shutterstock July 24, 2026 10:30 AM EDT R&DIn Focus Biogen’s Alzheimer’s data spur excitement, confusion about tau-targeting drugs Ryan Cross Senior Science Correspondent LONDON — One of the most anticipated Alzheimer’s studies in the past few years has created both enthusiasm and confusion, according to conversations Endpoints News recently … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that